Stay updated with breaking news from Sage therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
now they want the judge to set limits on what trump can share about the criminal case against him. they want to take away my freedom because i will never let them take away your freedoms. also tonight, wild weather. a serious threat of flooding. heavy rain. even tornadoes looming for parts of the country. while the heat dome intensifies its grip on the south and southwest. we ll have the latest forecast. plus, promising pill. the new drug just approved by the fda for those battling postpartum depression. it s going to save so many women and families. manhattan mayhem. fallout from the riot in new york s union square. the charges against the social media influencer who drew the massive mob. and later, do or die. the u.s. women s team on the brink of elimination at the world cup. they may be down, but don t count them out. there s no question we re highly motivated. announcer: this is the cbs weekend news, with adriana diaz. good evening. adriana is of ....
Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […] ....
AdvisorShares Investments LLC trimmed its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.6% in the fourth quarter, HoldingsChannel reports. The firm owned 13,362 shares of the biopharmaceutical company’s stock after selling 3,053 shares during the quarter. AdvisorShares Investments LLC’s holdings in Sage Therapeutics were worth $290,000 as of its most […] ....
AdvisorShares Investments LLC lessened its holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,362 shares of the biopharmaceutical company’s stock after selling 3,053 shares during the period. AdvisorShares Investments LLC’s holdings in […] ....